Further to the announcement by Psyence Group Inc. (Psyence Group) of the closing (Closing) of the business combination of its subsidiary, Psyence Biomedical Ltd. (PBM) with Newcourt Acquisition Corp. (Newcourt) (Business Combination or Spin-Out). Dr. Neil Maresky has assumed the role of CEO of PBM to oversee the Psyence Biomed business and has resigned as CEO of Psyence Group.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 CAD | +20.00% | 0.00% | -40.00% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-40.00% | 3.06M | |
+1.77% | 42.86B | |
+47.70% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |
- Stock Market
- Equities
- PSYG Stock
- News Psyence Group Inc.
- Psyence Group Inc. Announces Resignation of Neil Maresky as CEO